- Clinical Trials
- November 2024
- 450 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2024
- 450 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- October 2024
- 1800 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- January 2025
- 456 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- December 2024
- 313 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- December 2024
- 581 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2025
- 180 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- September 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 210 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 144 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2025
- 218 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 92 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- November 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP

Prostate cancer is a type of cancer that affects the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. It is the most common cancer in men in the United States, and the second most common cause of cancer death in men. Prostate cancer is typically treated with surgery, radiation therapy, hormone therapy, chemotherapy, or a combination of these treatments.
The prostate cancer market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to benefit from the introduction of novel therapies, such as immunotherapies and targeted therapies, which are expected to improve the prognosis of patients. Additionally, the increasing focus on early diagnosis and the development of new diagnostic tools are expected to drive the market growth.
Some of the key players in the prostate cancer market include AstraZeneca, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi. Show Less Read more